← Back to Search

Characterization of Visceral Adiposity in HIV Mono-infected Patients With NAFLD (Theratech Trial)

N/A
Waitlist Available
Led By Giada Sebastiani
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
No Placebo-Only Group

Summary

To determine the distribution of visceral fat in people living with HIV (PLHIV) with NAFLD by clinical anthropometric indicators (wais-to-hip ratio), lipid accumulation product (waist circumference and triglycerides) and radiological techniques such as dual-energy X-ray absorptiometry (DXA) (trunk fat mass and fat mass through dual-energy X-ray absorptiometry).

Eligible Conditions
  • Fatty Liver Disease
  • HIV (Human Immunodeficiency Virus)
  • Non-alcoholic Fatty Liver Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Determination of visceral fat

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: HIV with NAFLDActive Control3 Interventions
HIV Nonalcoholic fatty liver disease patients
Group II: HIV without NAFLDActive Control3 Interventions
HIV without Nonalcoholic fatty liver disease patients

Find a Location

Who is running the clinical trial?

McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
471 Previous Clinical Trials
166,927 Total Patients Enrolled
4 Trials studying Non-alcoholic Fatty Liver Disease
200 Patients Enrolled for Non-alcoholic Fatty Liver Disease
Giada SebastianiPrincipal InvestigatorMcGill University Health Centre/Research Institute of the McGill University Health Centre
2 Previous Clinical Trials
67 Total Patients Enrolled
2 Trials studying Non-alcoholic Fatty Liver Disease
67 Patients Enrolled for Non-alcoholic Fatty Liver Disease
~6 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top